[{"address1": "22 Einstein Street", "address2": "Floor 4", "city": "Ness Ziona", "zip": "7414003", "country": "Israel", "phone": "972 7 2394 2377", "website": "https://www.biomx.com", "longBusinessSummary": "BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.", "fullTimeEmployees": 58, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jonathan Eitan Solomon MBA", "age": 46, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 714367, "exercisedValue": 0, "unexercisedValue": 3978}, {"maxAge": 1, "name": "Ms. Marina  Wolfson CPA", "age": 39, "title": "CFO & Secretary", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 337514, "exercisedValue": 0, "unexercisedValue": 153}, {"maxAge": 1, "name": "Dr. Merav  Bassan Ph.D.", "age": 57, "title": "Chief Development Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 437713, "exercisedValue": 0, "unexercisedValue": 1149}, {"maxAge": 1, "name": "Prof. Rotem  Sorek Ph.D.", "title": "Scientific Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eran  Elinav M.D., Ph.D.", "title": "Scientific Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Timothy K. Lu M.D., Ph.D.", "age": 42, "title": "Scientific Founder", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inbal  Benjamini-Elran", "title": "C.H.R.O", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Assaf  Oron", "age": 49, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 352037, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.16, "open": 0.9, "dayLow": 0.9, "dayHigh": 0.9, "regularMarketPreviousClose": 1.16, "regularMarketOpen": 0.9, "regularMarketDayLow": 0.9, "regularMarketDayHigh": 0.9, "beta": 1.296, "forwardPE": -0.34615386, "volume": 1100, "regularMarketVolume": 1100, "averageVolume": 6133, "averageVolume10days": 3884, "averageDailyVolume10Day": 3884, "bid": 0.7777, "bidSize": 1000, "askSize": 900, "fiftyTwoWeekLow": 0.244801, "fiftyTwoWeekHigh": 12.05, "fiftyDayAverage": 1.6216686, "twoHundredDayAverage": 2.1940985, "currency": "USD", "enterpriseValue": 26811260, "floatShares": 13823645, "heldPercentInstitutions": 0.00013, "bookValue": -0.716, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -26253000, "trailingEps": -1.311, "forwardEps": -2.6, "lastSplitFactor": "0.1:1", "lastSplitDate": 1724630400, "enterpriseToEbitda": -0.967, "52WeekChange": -0.78571427, "SandP52WeekChange": 0.31426477, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "PHGE-UN", "underlyingSymbol": "PHGE-UN", "shortName": "BiomX Inc.", "longName": "BiomX Inc.", "firstTradeDateEpochUtc": 1572528600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "8a3674e0-b90e-3e82-9d6c-8249ef934507", "messageBoardId": "finmb_430935769", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.9, "targetHighPrice": 20.0, "targetLowPrice": 12.0, "targetMeanPrice": 16.0, "targetMedianPrice": 16.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 31611000, "totalCashPerShare": 1.766, "ebitda": -27712000, "totalDebt": 9896000, "quickRatio": 4.423, "currentRatio": 4.802, "debtToEquity": 36.084, "returnOnAssets": -0.32654998, "returnOnEquity": -1.21289, "freeCashflow": -17369000, "operatingCashflow": -34757000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]